Cargando…

Safety and reactogenicity of second booster doses for mRNA vaccines

Detalles Bibliográficos
Autores principales: Wilder-Smith, Annelies, Kochhar, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674367/
https://www.ncbi.nlm.nih.gov/pubmed/36410365
http://dx.doi.org/10.1016/S2213-2600(22)00451-9
_version_ 1784833138502926336
author Wilder-Smith, Annelies
Kochhar, Sonali
author_facet Wilder-Smith, Annelies
Kochhar, Sonali
author_sort Wilder-Smith, Annelies
collection PubMed
description
format Online
Article
Text
id pubmed-9674367
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-96743672022-11-21 Safety and reactogenicity of second booster doses for mRNA vaccines Wilder-Smith, Annelies Kochhar, Sonali Lancet Respir Med Comment Published by Elsevier Ltd. 2023-02 2022-11-18 /pmc/articles/PMC9674367/ /pubmed/36410365 http://dx.doi.org/10.1016/S2213-2600(22)00451-9 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Wilder-Smith, Annelies
Kochhar, Sonali
Safety and reactogenicity of second booster doses for mRNA vaccines
title Safety and reactogenicity of second booster doses for mRNA vaccines
title_full Safety and reactogenicity of second booster doses for mRNA vaccines
title_fullStr Safety and reactogenicity of second booster doses for mRNA vaccines
title_full_unstemmed Safety and reactogenicity of second booster doses for mRNA vaccines
title_short Safety and reactogenicity of second booster doses for mRNA vaccines
title_sort safety and reactogenicity of second booster doses for mrna vaccines
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674367/
https://www.ncbi.nlm.nih.gov/pubmed/36410365
http://dx.doi.org/10.1016/S2213-2600(22)00451-9
work_keys_str_mv AT wildersmithannelies safetyandreactogenicityofsecondboosterdosesformrnavaccines
AT kochharsonali safetyandreactogenicityofsecondboosterdosesformrnavaccines